Wes Streeting Proposes Capital Gains Tax Reform in Labour Leadership Bid Box Office Tracking Suggests The Mandalorian Grogu Could Face Similar Opening to Disneys Solo Micron Signals AI Boom Sustainability Accelerates Singapore Investment Market Cap Surge for Top Indian Firms Reliance Leads 74111 Crore Gain Corporate Confidence in Prediction Markets Grows Despite Regulatory Uncertainty Nuclear Startup Newcleo to Go Public on Nasdaq at 24 Billion Valuation AEP Q1 2026 Earnings Earnings Beat Estimates Driven by Operational Strength QURE Q1 2026 Earnings NarrowerthanExpected Loss as Gene Therapy Developer Continues Pipeline Progress BHFAM Q1 2026 Earnings Preferred Stock EPS Falls Short of Expectations Amid Mixed Operating Environment MAGN Q1 2026 Earnings Wide EPS Miss Signals Operational Pressure MFAO Q1 2026 Earnings Slight EPS Miss Amid Stable Business Conditions BRC Group Holdings RILYZ Q1 2024 Earnings Bondholder Impact Amid No Revenue Visibility and Negative EPS Zoetis ZTS Edges Lower Amid Sector Volatility Key Levels in Focus IRIDEX Corporation IRIX Holds Steady at 101 as Key Support and Resistance Levels Tighten Futu Holdings FUTU Surges 17 Breaking Resistance or Nearing Overextension Clorox CLX Gains Ground Consumer Staples Stock Rebounds Amid Defensive Demand Tempus AI Inc TEM Holds Steady Near Support as Momentum Fades Russia Warns US Citizens to Leave Kyiv as Moscow Announces Systematic Strikes on Ukrainian Capital CleanSpark CLSK Q1 2026 Earnings Deep EPS Miss Fails to Dampen Investor Sentiment Oculis Holding AG Warrants OCSAW Hold Steady Near Support as Market Awaits Catalysts Virgin Galactic Q1 2026 Earnings Loss Narrows as Company Reports BetterThanExpected EPS Betterware de Mexico BWMX Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Shares Edge Higher GAIA Q1 2026 Earnings EPS Falls Short of Estimates Stock Rises 166 on Strategic Progress COYA Q1 2026 Earnings NarrowerthanExpected Loss as Biotech Advances Pipeline TTM Technologies Q1 2026 Earnings EPS Surprises to the Upside Amid Strong Operating Execution FibroBiologics FBLG Q1 2026 Earnings Narrow EPS Miss as PreRevenue Biotech Continues RD Investment MGEE Q1 2026 Earnings EPS Surpasses Estimates on Strong Utility Performance